ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

Hepatic angiosarcoma (HAS) is a rare and highly lethal malignancy with few effective systemic treatments. Relatively little is known about the genetic abnormalities that drive this disease. As a result, there has been minimal progress towards applying targeted therapies to the treatment of HAS. We d...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Eric I., Pamarthy, Sahithi, Dizon, Don, Birnbaum, Ari, Yakirevich, Evgeny, Safran, Howard, Carneiro, Benedito A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349438/
https://www.ncbi.nlm.nih.gov/pubmed/30719217
http://dx.doi.org/10.18632/oncotarget.26521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349438/
https://www.ncbi.nlm.nih.gov/pubmed/30719217
http://dx.doi.org/10.18632/oncotarget.26521

Ejemplares similares